Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00835133
Other study ID # 355-06
Secondary ID R01CA097075-08CD
Status Recruiting
Phase
First received
Last updated
Start date August 1, 2002
Est. completion date September 30, 2024

Study information

Verified date June 2024
Source Mayo Clinic
Contact Adriana M Delgado, MA.CCRP
Phone 1-800-914-7962
Email pancreas@mayo.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

RATIONALE: Collecting and storing samples of blood and tissue from family members of patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This clinical trial is collecting blood and tissue samples from family members of patients with pancreatic disease, pancreatic cancer, and melanoma.


Description:

OBJECTIVES: - To collect clinical history, family history, and blood and/or tissue samples from family members of patients diagnosed with pancreatic diseases, pancreatic cancer, or melanoma. - To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic cancer, or other cancers. OUTLINE: Study participants undergo collection of blood and/or tissue samples as well as survey data for inclusion in a familial data and tissue registry. Participants complete two baseline surveys regarding their personal, family, health, and environmental exposure histories and regarding their opinions on cancer and cancer screening. Patients also complete a follow-up survey at 1 year and undergo review of their medical records.


Recruitment information / eligibility

Status Recruiting
Enrollment 12000
Est. completion date September 30, 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 120 Years
Eligibility DISEASE CHARACTERISTICS: - Meets 1 of the following criteria: - Has at least 2 blood relatives with pancreatic cancer (both must be related) - Has at least 1 blood relative with pancreatic cancer and 1 with melanoma (both must be related) PATIENT CHARACTERISTICS: - Mentally competent and able to provide informed consent - Able to understand and read English PRIOR CONCURRENT THERAPY: - Not specified

Study Design


Related Conditions & MeSH terms


Intervention

Other:
biologic sample preservation procedure
one blood sample
medical chart review
confirmation of cancer diagnosis
survey administration
at baseline enrollment and 12 months post-enrollment

Locations

Country Name City State
United States Mayo Clinic Cancer Center Rochester Minnesota

Sponsors (2)

Lead Sponsor Collaborator
Mayo Clinic National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Collection of familial data and biospecimens in a data and tissue repository for familial pancreas research baseline
See also
  Status Clinical Trial Phase
Recruiting NCT04104230 - Quebec Pancreas Cancer Study
Recruiting NCT02070705 - DCE MRI in Patients With Pancreatic Cancer N/A
Completed NCT03693378 - A Study of IMMrayâ„¢ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups
Active, not recruiting NCT04247503 - Cohort Study of Pancreatic Cancer Risk
Recruiting NCT04743479 - Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
Completed NCT02560896 - Understanding Genetic Incidental Findings in Your Family (UNIFY Study)
Recruiting NCT04095195 - Registry of Subjects at Risk of Pancreatic Cancer
Active, not recruiting NCT02206360 - Pancreatic Cancer Early Detection Program

External Links